• Tue news: Merck's Keytruda stages comeback in head and neck cancer. GSK, Pfizer RSV vaccine sales fall. Astellas gene therapy bet. Extreme weather —>drug shortages. J&J discontinues bladder cancer drug. See more on our front page

Pfizer

Anonymous board for Pfizer.
Replies
0
Views
742
Anonymous
Replies
16
Views
2K
Anonymous
Replies
7
Views
1K
Anonymous
Replies
0
Views
1K
Anonymous
Replies
0
Views
723
Anonymous
Replies
4
Views
2K
Anonymous
Replies
0
Views
2K
Anonymous
Replies
0
Views
2K
Anonymous
Replies
10
Views
2K
Anonymous